ArticleTranslational pediatrics2026
Nasal intermittent positive pressure ventilation versus nasal continuous positive airway pressure as initial respiratory support during minimally invasive surfactant therapy in preterm infants with respiratory distress syndrome: a retrospective real-world cohort study.
Article in Translational pediatrics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Nasal continuous positive airway pressure (NCPAP) and nasal intermittent positive pressure ventilation (NIPPV) are commonly used as initial non-invasive respiratory support in preterm infants with respiratory distress syndrome (RDS). Minimally invasive surfactant therapy (MIST) is increasingly used to reduce exposure to endotracheal intubation, but data on NIPPV compared to NCPAP during MIST remain limited. This study aimed to compare NIPPV and NCPAP as initial respiratory support during MIST in preterm infants with RDS, with the primary outcome of invasive mechanical ventilation within the first 72 h of life. Methods: This single-center, retrospective, real-world cohort study included preterm infants (<37 weeks of gestation) with RDS who received MIST within 6 h after birth between January 2021 and January 2025. Infants were grouped according to the initial mode of non-invasive respiratory support: NIPPV (n=170) or NCPAP (n=130). The primary outcome measure was invasive mechanical ventilation (IMV) within the first 72 h of life. Between-group comparisons, multivariable logistic regression adjusted for gestational age and birth weight, inverse probability of treatment weighting, and gestational-age subgroup analyses were performed. Secondary outcome measures included neonatal morbidities, respiratory-support duration, length of hospital stay, surfactant use, and blood gas changes. Results: Infants in the NIPPV group had lower gestational age (31.37±2.09 Conclusions: In preterm infants with RDS receiving MIST, initial NIPPV and NCPAP were associated with no statistically significant difference in IMV requirement within 72 h after accounting for major baseline imbalances. NIPPV appears to be a feasible alternative to NCPAP in this setting, but this retrospective study cannot establish non-inferiority or causality. Larger multicenter randomized studies with prespecified stratification are warranted.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.